“The fact that the Commission nevertheless persists in the view that snus causes cancer is both surprising and, to be honest, quite remarkable,” said Skyttedal as quoted by Snusforumet. Snus is a moist powder tobacco product that is placed under the upper lip for extended periods. It is mostly popular in Sweden, Denmark and Norway, where it is legal and considered an effective harm reduction product.
In fact, as the MEP rightly highlighted, snus has not only led to Sweden boasting the lowest smoking rates in Europe, but also to reducing Sweden’s tobacco-related deaths by half the EU average, despite leaving the overall tobacco usage on par with the EU average. “If the Tobacco Products Directive is to be revised to take account of the fight against cancer, does the Commission share the view that the EU needs to change its regulation of snus?” Skyttedal asked Commissioner Kyriakides.
EC Commissioner inaccurately links snus to cancer
In response to the MEP’s arguments, sadly the Commissioner Kyriakides said that the EC’s stance remains unchanged as snus and other oral tobacco products have been linked to cancer and other adverse health effects. “It is undisputed that tobacco for oral use is addictive and has adverse health effects, including cancers.” Kyriakides went on to cite a 2008 report from the EU’s Scientific Committee on Emerging and Newly Identified Health Risk which she says “confirmed the negative health effects of snus”.
The Commissioner’s response prompted a strong reaction from Skyttedal, who pointed out that actually most studies related to snus found little or no links to cancer, and went on to cite the Lancet’s Global Burden of Diseases as well as a 2020 study published in the Scandinavian Journal of Public Health, both of which conclude there is no evidence to suggest a link between snus and cancer.
Read Further: Snusforumet
